| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -1.3 | -1.3 |
| EPS (diluted, $ a share) | $-0.00 | $-0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-Q filed with the SEC, OTC: PVCT. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Provectus Biopharmaceuticals, Inc.: key numbers
- Share price
- $0.0459Close, Nov 16
- Market cap
- $19.3M
- Shares outstanding
- 420.28MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.